Enhabit, Inc. (EHAB)

Market Cap	532.39M
Revenue (ttm)	1.05B
Net Income (ttm)	-11.90M
Shares Out	50.61M
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	19.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	364,095
Open	10.81
Previous Close	10.89
Day's Range	10.52 - 10.84
52-Week Range	6.47 - 11.27
Beta	1.28
Analysts	Strong Buy
Price Target	12.00 (+14.07%)
Earnings Date	Mar 4, 2026

About EHAB

Enhabit, Inc. provides home health and hospice services in the United States. The company’s home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2014
• Employees: 10,700
• Stock Exchange: NYSE
• Ticker Symbol: EHAB
• Website: https://www.ehab.com

Financial Performance

In 2024, Enhabit's revenue was $1.03 billion, a decrease of -1.10% compared to the previous year's $1.05 billion. Losses were -$156.20 million, 94.0% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for EHAB stock is "Strong Buy." The 12-month stock price target is $12.0, which is an increase of 14.07% from the latest price.

Price Target

$12.0

(14.07% upside)

Analyst Consensus: Strong Buy